Recent publications described many discrepant findings about thyroid “stunning” after the
administration of 131I diagnostic activities to patients with differentiated thyroid carcinoma …

Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …

Background: There is a growing belief that a pretherapy scan yields little or no additional
information that would impact on radioiodine ablation dosing. In addition, there is some …

Stunning of thyroid tissue by diagnostic activities of 131I has been described by some
investigators and refuted by others. The support both for and against stunning has at times …

Purpose Using 123 I for diagnostic purposes avoids the risk of stunning for subsequent
radioiodine treatment and affords an excellent image quality. In this study we assessed the …

Recent clinical and experimental data demonstrate that thyroid stunning is caused by
previous irradiation and may influence the efficacy of 131I radiation therapy of thyroid cancer …

The thyroid gland was one of the first organs imaged in nuclear medicine, beginning in the
1940s. Thyroid scintigraphy is based on a specific phase or prelude to thyroid hormone …

El cáncer diferenciado de tiroides es la neoplasia endocrina más común y su incidencia
parece aumentar rápidamente, aunque con un buen pronóstico; la participación de diversas …

Differentiated thyroid carcinoma (DTC) has been increasing in incidence in the United
States over the last several decades, although mortality rates have remained low …

Background High iodine uptake levels are widely accepted as a condition for successful
treatment with radioiodine (RAI). However, the existing data are controversial and the …